Panconesi A, Del Bianco P L, Curradi C, Franchi G, Anselmi B, Andreini R
Istituto di Clinica Medica Generale e Terapia Medica IV, Università degli Studi di Firenze.
Clin Ter. 1991 May 15;137(3):169-83.
Headache induced by ergotamine-abuse was described 40 years ago. More recently there is ample evidence suggesting that chronic headache may also be provoked by analgesic abuse. A recent Classification of the International Headache Society has defined this kind of headache as an autonomous disease. It consists in a daily chronic headache with paroxysmal attacks associated with daily or almost daily assumption of analgesics and/or ergotamine. It is debated whether the term "abuse" or "dependence" is correct. Almost 5% of patients of the Headache Centres in Italy were found to be drug abusers. Most of these patients originally suffered from migraine. The therapeutic approach consists in hospitalization, withdrawal of analgesics and/or ergotamine, treatment of the withdrawal headache (which appears within 48 hours and lasts even 1-2 weeks) and finally in a prophylactic therapy. Although several treatments have been suggested for the abstinence syndrome, only fluid replacement, antiemetics, hypnotic-sedative drugs and rarely mild analgesics are necessary. A review of the literature shows the following success rates in the relief of the headache: above 50% relief in more than 60% of patients within a follow up period of 1 to 3.5 years as mean. Even if caffeine and barbiturates, which are often contained in the analgesic and ergotamine preparations, might be considered the cause of the abuse and withdrawal syndrome, they don't seem to play a fundamental role in this syndrome. An impairment of the central antinociceptive system was hypothesized to be involved in the pathogenesis of the headache associated with analgesic and/or ergotamine abuse. Recently there has been evidence of a possible hyposensitivity of the adrenergic and serotoninergic receptors of the central nervous system. It is still to be proved whether drug abuse is the cause or the consequence of the headache chronicization. The remarkable improvement of headache after analgesic withdrawal suggests a causal factor.
40年前就有关于麦角胺滥用所致头痛的描述。最近,有充分证据表明慢性头痛也可能由镇痛药滥用引发。国际头痛协会最近的分类将这类头痛定义为一种独立的疾病。它表现为每日慢性头痛,伴有阵发性发作,与每日或几乎每日服用镇痛药和/或麦角胺有关。对于“滥用”还是“依赖”这一术语是否正确存在争议。在意大利的头痛中心,近5%的患者被发现是药物滥用者。这些患者大多最初患有偏头痛。治疗方法包括住院、停用镇痛药和/或麦角胺、治疗戒断性头痛(在48小时内出现,甚至持续1 - 2周),最后进行预防性治疗。尽管针对戒断综合征提出了几种治疗方法,但仅补充液体、使用止吐药、催眠镇静药物,很少情况下使用轻度镇痛药就足够了。文献综述显示头痛缓解的成功率如下:在1至3.5年的平均随访期内,超过60%的患者头痛缓解程度超过50%。即使镇痛药和麦角胺制剂中常含有的咖啡因和巴比妥类药物可能被认为是滥用和戒断综合征的原因,但它们在该综合征中似乎并不起根本作用。据推测,中枢抗伤害感受系统的损害参与了与镇痛药和/或麦角胺滥用相关头痛的发病机制。最近有证据表明中枢神经系统的肾上腺素能和5-羟色胺能受体可能存在低敏性。药物滥用是头痛慢性化的原因还是结果仍有待证实。停用镇痛药后头痛明显改善提示存在因果关系。